Results 101 to 110 of about 9,204,525 (344)
Economic costs of Chagas disease in Colombia in 2017: A social perspective
Objective: To quantify the costs of Chagas disease in Colombia from a societal perspective in 2017. Methods: A cost-of-illness analysis was carried out using a prevalence-based approach.
Mario J. Olivera, Giancarlo Buitrago
doaj +1 more source
'It is like a tomato stall where someone can pick what he likes': structure and practices of female sex work in Kampala, Uganda. [PDF]
BACKGROUND: Effective interventions among female sex workers require a thorough knowledge of the context of local sex industries. We explore the organisation of female sex work in a low socio-economic setting in Kampala, Uganda.
A-M Cote+34 more
core +2 more sources
Chagas disease and immunosuppression [PDF]
Chagas disease, caused by a hemoflagellate,Trypanosoma cruzi, is a parasitic disease widelydistributed throughout Latin America. It is trans-mitted to man by hematophagous vectors (redu-viid bugs), blood transfusion and, more rarely, byoral route, laboratory accidents, and from motherto fetus.
openaire +4 more sources
ABSTRACT Aedes aegypti, a critical vector for tropical diseases, poses significant challenges for studying its embryogenesis due to difficulties in removing its rigid chorion and achieving effective fixation for in situ hybridization. Here, we present novel methodologies for fixation, dechorionation, DAPI staining, and in situ hybridization, enabling ...
Renata Coutinho‐dos‐Santos+8 more
wiley +1 more source
ABSTRACT Background Ayahuasca is an Amazonian psychedelic brew that contains dimethyltryptamine (DMT) and beta carbolines. Prolonged use has shown changes in cognitive‐behavioral tasks, and in humans, there is evidence of changes in cortical thickness and an increase in neuroplasticity factors that could lead to modifications in functional neural ...
Lucas Rego Ramos+2 more
wiley +1 more source
Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland
BACKGROUND Chronic cardiomyopathy occurs in 20-40% of the patients with Chagas disease. Autoimmune mechanisms may contribute to its pathogenesis. We diagnosed several cases of systemic autoimmune diseases among Bolivian migrants in Geneva with a high ...
Yves Jackson+4 more
doaj +1 more source
Repurposing of terconazole as an anti Trypanosoma cruzi agent [PDF]
Trypanosoma cruzi is the causative agent of Chagas disease, a parasitic infection endemic in Latin America. Currently there are no effective treatments for the chronic phase of the disease, when most patients are diagnosed, therefore the development of ...
Martínez Sayé, Melisa Soledad+4 more
core +1 more source
Protective Properties of the White Button Mushroom, Agaricus bisporus, in a Mouse Model of Colitis
In this study, whole mushroom powder (WMP) from white button mushrooms was tested for gut health benefits. In vitro digested WMP (IVD‐WMP) could reduce the permeability of a gastrointestinal cell layer. In mouse studies, WMP was tested as a preventative and a treatment for dextran sulfate sodium (DSS) induced colitis. WMP could improve recovery, reduce
Elaine Dempsey+5 more
wiley +1 more source
Mapping of Chagas disease research: analysis of publications in the period between 1940 and 2009
INTRODUCTION: Publications are often used as a measure of success in research work. Chagas disease occurs in Central and Southern America. However, during the past years, the disease has been occurring outside Latin America due to migration from endemic ...
José Manuel Ramos+3 more
doaj +1 more source
Protective immunity against Trypanosoma cruzi [PDF]
Upon infection, Trypanosoma cruzi triggers a strong immune response that has both protective and pathological consequences. In this work, several important questions regarding protective immunity are reviewed.
Basombrío, Miguel Ángel Manuel+2 more
core +1 more source